Cargando…
Thymic tumours and their special features
Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequen...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488894/ https://www.ncbi.nlm.nih.gov/pubmed/34670805 http://dx.doi.org/10.1183/16000617.0394-2020 |
_version_ | 1784792762879574016 |
---|---|
author | Basse, Clémence Girard, Nicolas |
author_facet | Basse, Clémence Girard, Nicolas |
author_sort | Basse, Clémence |
collection | PubMed |
description | Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequencing. Association with autoimmune diseases, especially myasthenia gravis, is observed, which impacts the oncological management. Networks are being built at the national and international levels. This article provides an overview of the most recent findings in the diagnosis, staging, histology, and management strategies of thymic tumours. |
format | Online Article Text |
id | pubmed-9488894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-94888942022-11-14 Thymic tumours and their special features Basse, Clémence Girard, Nicolas Eur Respir Rev Series Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat. The pillars of the management include pathological review, consideration of differential diagnoses, staging and multidisciplinary discussion. Assessment of resectability is key to drive the treatment sequencing. Association with autoimmune diseases, especially myasthenia gravis, is observed, which impacts the oncological management. Networks are being built at the national and international levels. This article provides an overview of the most recent findings in the diagnosis, staging, histology, and management strategies of thymic tumours. European Respiratory Society 2021-10-20 /pmc/articles/PMC9488894/ /pubmed/34670805 http://dx.doi.org/10.1183/16000617.0394-2020 Text en Copyright ©The authors 2021 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
spellingShingle | Series Basse, Clémence Girard, Nicolas Thymic tumours and their special features |
title | Thymic tumours and their special features |
title_full | Thymic tumours and their special features |
title_fullStr | Thymic tumours and their special features |
title_full_unstemmed | Thymic tumours and their special features |
title_short | Thymic tumours and their special features |
title_sort | thymic tumours and their special features |
topic | Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488894/ https://www.ncbi.nlm.nih.gov/pubmed/34670805 http://dx.doi.org/10.1183/16000617.0394-2020 |
work_keys_str_mv | AT basseclemence thymictumoursandtheirspecialfeatures AT girardnicolas thymictumoursandtheirspecialfeatures |